Juana Fernandez shows her scar from breast cancer surgery at the Amama office in Seville Oncology patients Charo Castro (L), Anabel Cano (2L) and Amparo Perez (R) pose with Amama breast cancer ...

The European Medicines Agency (EMA) has validated the Type II Variation marketing authorization application for ENHERTU ® (trastuzumab deruxtecan) in combination with pertuzumab for the first-line ...

Hepatocellular carcinoma (HCC) remains a leading cause of cancer-related mortality worldwide, particularly in regions with ...

A scientist in the French city of Orleans holds up a test tube containing messenger RNA While mRNA was discovered in the early 1960s, it rose to global prominence when it was used in some Covid ...